Qlucore Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 12

Employees

  • Stock Symbol
  • QCORE

Stock Symbol

  • Share Price
  • $0.03
  • (As of Friday Closing)

Qlucore General Information

Description

Qlucore AB develops AI-based software that enables more accurate diagnoses and more cost-effective healthcare. Through the company's precision medicine solutions, tens of thousands of genetic data points are transformed into clear decision-making data, making it possible to provide the right treatment to every patient at the right time. In addition to its diagnostics portfolio, the company also offers Qlucore Omics Explorer software, an established tool for data analysis used by researchers and pharmaceutical companies globally.

Contact Information

Website
www.qlucore.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Ideon Science Park
  • Scheelevägen 17
  • 223 70 Lund
  • Sweden
+46 0628-631
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Stock Exchange
STO
Vertical(s)
Corporate Office
  • Ideon Science Park
  • Scheelevägen 17
  • 223 70 Lund
  • Sweden
+46 0628-631

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qlucore Stock Performance

As of 13-Nov-2026, Qlucore’s stock price is $0.03. Its current market cap is $1.37M with 42.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.02 - $0.06 $1.37M 42.9M 26.5K -$0.11

Qlucore Financials Summary

As of 31-Jul-2026, Qlucore has a trailing 12-month revenue of $814K.

In Thousands,
USD
TTM 31-Jul-2026 FY 2026 30-Apr-2026 FY 2025 30-Apr-2025 FY 2024 30-Apr-2024
EV 1,481 1,138 (243) 21
Revenue 814 717 966 1,350
EBITDA (2,735) (3,069) (1,522) (1,201)
Net Income (3,496) (3,886) (1,943) (1,473)
Total Assets 4,479 4,512 7,247 8,226
Total Debt 131 150 207 291
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Qlucore Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qlucore‘s full profile, request access.

Request a free trial

Qlucore Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Qlucore‘s full profile, request access.

Request a free trial

Qlucore Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Qlucore AB develops AI-based software that enables more accurate diagnoses and more cost-effective healthcare. Through t
Other Healthcare Technology Systems
Lund, Sweden
12 As of 2026

San Francisco, CA
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qlucore Competitors (11)

One of Qlucore’s 11 competitors is Benchling, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Benchling Venture Capital-Backed San Francisco, CA
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
DNAnexus Venture Capital-Backed San Francisco, CA
Strand (Biotechnology) Formerly VC-backed Bangalore, India
Genotypic Technology Corporation Bengaluru, India
You’re viewing 5 of 11 competitors. Get the full list »

Qlucore Patents

Qlucore Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2500837-A1 Method for robust comparison of data Inactive 11-Mar-2011
EP-2684150-A2 Method for robust comparison of data Active 11-Mar-2011
EP-2684150-B1 Method for robust comparison of data Active 11-Mar-2011
US-20140074864-A1 Method for robust comparison of data Inactive 11-Mar-2011
WO-2012123374-A2 Method for robust comparison of data Inactive 11-Mar-2011 G06Q30/02
To view Qlucore’s complete patent history, request access »

Qlucore Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qlucore Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Qlucore‘s full profile, request access.

Request a free trial

Qlucore ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Software & Services

Industry

Rank

Percentile

Enterprise and Infrastructure Software

Subindustry

Rank

Percentile

To view Qlucore’s complete esg history, request access »

Qlucore FAQs

  • When was Qlucore founded?

    Qlucore was founded in 2007.

  • Where is Qlucore headquartered?

    Qlucore is headquartered in Lund, Sweden.

  • What is the size of Qlucore?

    Qlucore has 12 total employees.

  • What industry is Qlucore in?

    Qlucore’s primary industry is Other Healthcare Technology Systems.

  • Is Qlucore a private or public company?

    Qlucore is a Public company.

  • What is Qlucore’s stock symbol?

    The ticker symbol for Qlucore is QCORE.

  • What is the current stock price of Qlucore?

    As of 13-Nov-2026 the stock price of Qlucore is $0.03.

  • What is the current market cap of Qlucore?

    The current market capitalization of Qlucore is $1.37M.

  • What is Qlucore’s current revenue?

    The trailing twelve month revenue for Qlucore is $814K.

  • Who are Qlucore’s competitors?

    Benchling, Oxford Nanopore Technologies, DNAnexus, Strand (Biotechnology), and Genotypic Technology are some of the 11 competitors of Qlucore.

  • What is Qlucore’s annual earnings per share (EPS)?

    Qlucore’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process